|
1
|
Weinreb RN, Aung T and Medeiros FA: The
pathophysiology and treatment of glaucoma: A review. JAMA.
311:1901–1911. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weinreb RN and Khaw PT: Primary open-angle
glaucoma. Lancet. 363:1711–1720. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
De Moraes CG, Liebmann JM and Levin LA:
Detection and measurement of clinically meaningful visual field
progression in clinical trials for glaucoma. Prog Retin Eye Res.
56:107–147. 2017. View Article : Google Scholar :
|
|
4
|
Pederson JE, Gaasterland DE and MacLellan
HM: Uveoscleral aqueous outflow in the rhesus monkey: Importance of
uveal reabsorption. Invest Ophthalmol Vis Sci. 16:1008–1017.
1977.PubMed/NCBI
|
|
5
|
Larsson LI, Rettig ES and Brubaker RF:
Aqueous flow in open-angle glaucoma. Arch Ophthalmol. 113:283–286.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tam LC, Reina-Torres E, Sherwood JM,
Cassidy PS, Crosbie DE, Lütjen-Drecoll E, Flügel-Koch C, Perkumas
K, Humphries MM, Kiang AS, et al: Enhancement of outflow facility
in the murine eye by targeting selected tight-junctions of
Schlemm's canal endothelia. Sci Rep. 7:407172017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bradley J, Vranka J, Colvis CM, Conger DM,
Alexander JP, Fisk AS, Samples JR and Acott TS: Effect of matrix
metalloproteinases activity on outflow in perfused human organ
culture. Invest Ophthalmol Vis Sci. 39:2649–2658. 1998.PubMed/NCBI
|
|
8
|
Vranka JA, Kelley MJ, Acott TS and Keller
KE: Extracellular matrix in the trabecular meshwork: Intraocular
pressure regulation and dysregulation in glaucoma. Exp Eye Res.
133:112–125. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wight TN and Potter-Perigo S: The
extracellular matrix: An active or passive player in fibrosis? Am J
Physiol Gastrointest Liver Physiol. 301:G950–G955. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wallace DM, Murphy-Ullrich JE, Downs JC
and O'Brien CJ: The role of matricellular proteins in glaucoma.
Matrix Biol. 37:174–182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brekken RA and Sage EH: SPARC, a
matricellular protein: At the crossroads of cell-matrix. Matrix
Biol. 19:569–580. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kuespert S, Junglas B, Braunger BM, Tamm
ER and Fuchshofer R: The regulation of connective tissue growth
factor expression influences the viability of human trabecular
meshwork cells. J Cell Mol Med. 19:1010–1020. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tamm ER: The trabecular meshwork outflow
pathways: Structural and functional aspects. Exp Eye Res.
88:648–655. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cela D, Brignole-Baudouin F, Labbé A and
Baudouin C: The trabecular meshwork in glaucoma: An inflammatory
trabeculopathy? J Fr Ophtalmol. 44:e497–e517. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shahid M, George TB, Saller J, Haija M,
Sayegh Z, Boulware D, Strosberg J, Chakrabarti R and Coppola D:
FGD4 (Frabin) overexpression in pancreatic neuroendocrine
neoplasms. Pancreas. 48:1307–1311. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sundararaman A and Mellor H: A functional
antagonism between RhoJ and Cdc42 regulates fibronectin remodelling
during angiogenesis. Small GTPases. 12:241–245. 2021. View Article : Google Scholar :
|
|
17
|
Ge J, Burnier L, Adamopoulou M, Kwa MQ,
Schaks M, Rottner K and Brakebusch C: RhoA, Rac1, and Cdc42
differentially regulate αSMA and collagen I expression in
mesenchymal stem cells. J Biol Chem. 293:9358–9369. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin J, Huang H, Lin L, Li W and Huang J:
MiR-23a induced the activation of CDC42/PAK1 pathway and cell cycle
arrest in human cov434 cells by targeting FGD4. J Ovarian Res.
13:902020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheema A, Chang RT, Shrivastava A and
Singh K: Update on the medical treatment of primary open-angle
glaucoma. Asia Pac J Ophthalmol (Phila). 5:51–58. 2016. View Article : Google Scholar
|
|
20
|
Rennie G, Wilkinson A, White A, Ruospo M,
Teixeira-Pinto A and Strippoli G: Topical medical therapy and
ocular perfusion pressure in open angle glaucoma: A systematic
review and meta-analysis. Curr Med Res Opin. 35:1421–1431. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Adams CM, Stacy R, Rangaswamy N, Bigelow
C, Grosskreutz CL and Prasanna G: Glaucoma-next generation
therapeutics: Impossible to possible. Pharm Res. 36:252018.
View Article : Google Scholar
|
|
22
|
Vaughan CJ and Delanty N: Neuroprotective
properties of statins in cerebral ischemia and stroke. Stroke.
30:1969–1973. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zacco A, Togo J, Spence K, Ellis A, Lloyd
D, Furlong S and Piser T: 3-hydroxy-3-methylglutaryl coenzyme A
reductase inhibitors protect cortical neurons from excitotoxicity.
J Neurosci. 23:11104–11111. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schmeer C, Kretz A and Isenmann S:
Statin-mediated protective effects in the central nervous system:
General mechanisms and putative role of stress proteins. Restor
Neurol Neurosci. 24:79–95. 2006.PubMed/NCBI
|
|
25
|
Song J, Deng PF, Stinnett SS, Epstein DL
and Rao PV: Effects of cholesterol-lowering statins on the aqueous
humor outflow pathway. Invest Ophthalmol Vis Sci. 46:2424–2432.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakagami H, Jensen KS and Liao JK: A novel
pleiotropic effect of statins: Prevention of cardiac hypertrophy by
cholesterol-independent mechanisms. Ann Med. 35:398–403. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wilson HL, Schwartz DM, Bhatt HR,
McCulloch CE and Duncan JL: Statin and aspirin therapy are
associated with decreased rates of choroidal neovascularization
among patients with age-related macular degeneration. Am J
Ophthalmol. 137:615–624. 2004.PubMed/NCBI
|
|
28
|
Polman CH and Killestein J: Statins for
the treatment of multiple sclerosis: Cautious hope. Lancet.
363:15702004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Endo A: The discovery and development of
HMG-CoA reductase inhibitors. J Lipid Res. 33:1569–1582. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Stein JD, Newman-Casey PA, Talwar N, Nan
B, Richards JE and Musch DC: The relationship between statin use
and open-angle glaucoma. Ophthalmology. 119:2074–2081. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McGwin G, McNeal S, Owsley C, Girkin C,
Epstein D and Lee PP: Statins and other cholesterol-lowering
medications and the presence of glaucoma. Arch Ophthalmol.
122:822–826. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Talwar N, Musch DC and Stein JD:
Association of daily dosage and type of statin agent with risk of
open-angle glaucoma. JAMA Ophthalmol. 135:263–267. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu H, Zeng L, Peng H, Chen S, Jones J,
Chew TL, Sadeghi MM, Kanwar YS and Danesh FR: HMG-CoA reductase
inhibitor simvastatin mitigates VEGF-induced 'inside-out' signaling
to extracellular matrix by preventing RhoA activation. Am J Physiol
Physiol. 291:F995–F1004. 2006. View Article : Google Scholar
|
|
34
|
Schaafsma D, Dueck G, Ghavami S, Kroeker
A, Mutawe MM, Hauff K, Xu FY, McNeill KD, Unruh H, Hatch GM and
Halayko AJ: The mevalonate cascade as a target to suppress
extracellular matrix synthesis by human airway smooth muscle. Am J
Respir Cell Mol Biol. 44:394–403. 2011. View Article : Google Scholar
|
|
35
|
Cong L, Fu S, Zhang J, Zhao J and Zhang Y:
Effects of atorvastatin on porcine aqueous humour outflow and
trabecular meshwork cells. Exp Ther Med. 15:210–216. 2018.
|
|
36
|
Shepard AR, Millar JC, Pang IH, Jacobson
N, Wang WH and Clark AF: Adenoviral gene transfer of active human
transforming growth factor-β2 elevates intraocular pressure and
reduces outflow facility in rodent eyes. Invest Ophthalmol Vis Sci.
51:2067–2076. 2010. View Article : Google Scholar
|
|
37
|
Fuchshofer R and Tamm ER: The role of
TGF-β in the pathogenesis of primary open-angle glaucoma. Cell
Tissue Res. 347:279–290. 2012. View Article : Google Scholar
|
|
38
|
Swaminathan SS, Oh DJ, Kang MH, Shepard
AR, Pang IH and Rhee DJ: TGF-β2-mediated ocular hypertension is
attenuated in SPARC-null mice. Invest Ophthalmol Vis Sci.
55:4084–4097. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang WH, Millar JC, Pang IH, Wax MB and
Clark AF: Noninvasive measurement of rodent intraocular pressure
with a rebound tonometer. Invest Ophthalmol Vis Sci. 46:4617–4621.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Stamer WD, Roberts BC, Epstein DL and
Allingham RR: Isolation of primary open-angle glaucomatous
trabecular meshwork cells from whole eye tissue. Curr Eye Res.
20:347–350. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Stamer WD and Clark AF: The many faces of
the trabecular meshwork cell. Exp Eye Res. 158:112–123. 2017.
View Article : Google Scholar :
|
|
42
|
Jurisic V, Srdic-Rajic T, Konjevic G,
Bogdanovic G and Colic M: TNF-α induced apoptosis is accompanied
with rapid CD30 and slower CD45 shedding from K-562 cells. J Membr
Biol. 239:115–122. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gracey AY, Fraser EJ, Li W, Fang Y, Taylor
RR, Rogers J, Brass A and Cossins AR: Coping with cold: An
integrative, multitissue analysis of the transcriptome of a
poikilothermic vertebrate. Proc Natl Acad Sci. 101:16970–16975.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kanehisa M, Goto S, Kawashima S, Okuno Y
and Hattori M: The KEGG resource for deciphering the genome.
Nucleic Acids Res. 32:D277–D280. 2004. View Article : Google Scholar :
|
|
45
|
O'Brien ET, Kinch M, Harding TW and
Epstein DL: A mechanism for trabecular meshwork cell retraction:
ethacrynic acid initiates the dephosphorylation of focal adhesion
proteins. Exp Eye Res. 65:471–483. 1997. View Article : Google Scholar
|
|
46
|
Honjo M and Tanihara H: Impact of the
clinical use of ROCK inhibitor on the pathogenesis and treatment of
glaucoma. Jpn J Ophthalmol. 62:109–126. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Faralli JA, Schwinn MK, Gonzalez JM Jr,
Filla MS and Peters DM: Functional properties of fibronectin in the
trabecular meshwork. Exp Eye Res. 88:689–693. 2009. View Article : Google Scholar :
|
|
48
|
Eliáš M and Klimeš V: Rho GTPases:
Deciphering the evolutionary history of a complex protein family.
Methods Mol Biol. 827:13–34. 2012. View Article : Google Scholar
|
|
49
|
Wang CY, Liu PY and Liao JK: Pleiotropic
effects of statin therapy: Molecular mechanisms and clinical
results. Trends Mol Med. 14:37–44. 2008. View Article : Google Scholar
|
|
50
|
Liu HP, Chen CC, Wu CC, Huang YC, Liu SC,
Liang Y, Chang KP and Chang YS: Epstein-Barr virus-encoded LMP1
interacts with FGD4 to activate Cdc42 and thereby promote migration
of nasopharyngeal carcinoma cells. PLoS Pathog. 8:e10026902012.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Bhoopathi P, Gondi CS, Gujrati M, Dinh DH
and Lakka SS: SPARC mediates Src-induced disruption of actin
cytoskeleton via inactivation of small GTPases Rho-Rac-Cdc42. Cell
Signal. 23:1978–1987. 2011. View Article : Google Scholar : PubMed/NCBI
|
